Novartis

...cell culture-based Influenza A(H1N1) 2009 monovalent vaccine, Celtura®. Novartis continues to pursue registration in other major countries, including Japan and Switzerland. Celtura is manufactured in Marburg, Germany and is an MF59® adjuvanted...

In this article: Germany, Influenza vaccine, Europe, US Department Of Health And Human Services, US, Marburg, Medical advice, and Google map

...- Added 3m ago BASEL, Switzerland - Swiss pharmaceutical company Novartis AG said today it has received regulatory approval in Switzerland for a swine flu vaccine produced using cell cultures instead of egg-based methods. The company last...

In this article: Novartis AG, All rights reserved, Switzerland, Basel, Europe, Washington, Japan, Germany, and Associated Press

It will be offered in multi-vial doses and in single dose pre-filled syringes. Celtura is manufactured in Marburg, Germany and includes Novartis adjuvant, MF59®. Adjuvants bolster the body's immune response, which means a smaller amount of...

In this article: H1N1, Chris Dodd, Department of Health and Human Services, Influenza, Wall Street, New York City, Cancer, AARP, and Connecticut

...of egg-based methods. Novartis described the approval as a "milestone" and said it is pursuing registration of the vaccine, marketed under the name Celtura, in other major countries, including Japan and Switzerland. With demand high...

In this article: Germany, Marburg, Europe, North Carolina, Japan, and Switzerland

Novartis starts swine flu vaccine tests Swiss drugmaker Novartis has begun injecting its swine flu vaccine into people in the company's first human tests, a spokesman said on Wednesday. The vaccine is being tested in a yearlong trial of...

In this article: Novartis AG, United States, European Medicines Agency, Sanofi, Europe, Britain, World Health Organisation, and Glaxo

...starts testing its swine flu vaccine LONDON Swiss drugmaker Novartis has begun injecting its swine flu vaccine into people in the company's first human tests, a spokesman said Wednesday. </p><p>The vaccine is being tested in a...

In this article: FLU, Novartis AG, United States, European Medicines Agency, Sanofi, India, and Europe

...turned out. Researchers from the Novartis pharmaceutical company, testing their swine flu vaccine this September, were astounded to find that just one dose was sufficient to produce copious antibodies in their inoculated patients. Similar...

In this article: Influenza, GlaxoSmithKline, World Health Organization, Germany, H1N1, and China